Are doctors prescribing antithrombin correctly? a new study investigates
NCT ID NCT07276074
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks back at how antithrombin, a blood-clotting protein, was prescribed to 160 intensive care patients at Strasbourg University Hospitals over two years. Researchers want to see if these prescriptions were appropriate and how the drug was used in real-world settings. The goal is to improve future prescribing practices.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- antithrombin
- What this could lead to
- If successful, this study could help hospitals create guidelines for better use of antithrombin, potentially improving patient safety and treatment effectiveness.
- What could go wrong
- This is a retrospective review, not a treatment trial. It only looks at past records, so it cannot prove cause and effect or change current care directly.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANTITHROMBINEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Service d'Anesthésie et Réanimation chirurgicale - CHU de Strasbourg - France
RECRUITINGStrasbourg, France